RedHill Biopharma Ltd. Stock Analysis & AI Score
RedHill Biopharma Ltd. (RDHL) has an ST Score of 40.8 (C), driven by its Growth (A-) and held back by its Momentum (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
RedHill Biopharma Ltd. (RDHL) has an ST Score of 40.8 (C), driven by its Growth (A-) and held back by its Momentum (F). Analysts rate it Buy.
- Strongest
- GrowthA-
- Weakest
- MomentumF
All factor grades
- GrowthA-
- ValuationB+
- Financial StrengthC
- ProfitabilityD+
- MomentumF
- Piotroski3/9
Contact
RDHL stock: frequently asked questions
What is RDHL's ST Score?
RedHill Biopharma Ltd. (RDHL) has an ST Score of 40.8 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is RDHL a buy, hold, or sell?
Analysts rate RDHL a Buy. Our ST Score grades it C (40.8/100). The ST Score is a data-driven signal, not a recommendation.
What are RDHL's factor grades?
Valuation B+, Profitability D+, Financial Strength C, Momentum F, Growth A-.
What is RDHL's valuation grade?
RedHill Biopharma Ltd. (RDHL) earns a valuation grade of B+, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is RDHL's growth grade?
RedHill Biopharma Ltd. (RDHL) earns a growth grade of A-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is RDHL's profitability grade?
RedHill Biopharma Ltd. (RDHL) earns a profitability grade of D+, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is RDHL's financial strength grade?
RedHill Biopharma Ltd. (RDHL) earns a financial strength grade of C, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is RDHL's Piotroski score?
RedHill Biopharma Ltd. (RDHL) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.